Published in Nephron Exp Nephrol on January 01, 2003
Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant (2010) 2.35
Human vascular smooth muscle cells express functionally active endothelial cell protein C receptor. Circ Res (2006) 2.17
Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila) (2011) 2.03
Alternatively spliced human tissue factor (asHTF) is not pro-coagulant. Thromb Haemost (2007) 1.75
Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis (2002) 1.62
Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Heart (2010) 1.53
A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferation. Thromb Haemost (2012) 1.41
Biocompatibility of a bicarbonate/lactate-buffered PD fluid tested with a double-chamber cell culture system. Perit Dial Int (2005) 1.39
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis. Kidney Int (2011) 1.37
A cell-based approach to the minimization of immunosuppression in renal transplantation. Transpl Int (2008) 1.24
Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy. Am J Kidney Dis (2006) 1.24
Prevention of dipyrone (metamizole) induced inhibition of aspirin antiplatelet effects. Thromb Haemost (2015) 1.14
Surgical treatment of renal artery dissection in 25 patients: indications and results. J Vasc Surg (2003) 1.11
Management of arterial stenosis affecting kidney graft perfusion: a single-centre study in 53 patients. Am J Transplant (2005) 1.09
Obligatory role of cyclic adenosine monophosphate response element in cyclooxygenase-2 promoter induction and feedback regulation by inflammatory mediators. Circulation (2002) 1.04
Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation. Endocrinology (2002) 1.01
Towards a definition of aspirin resistance: a typological approach. Platelets (2002) 1.00
Dipyrone (metamizole) can nullify the antiplatelet effect of aspirin in patients with coronary artery disease. J Am Coll Cardiol (2013) 1.00
Microglia activation in hepatic encephalopathy in rats and humans. Hepatology (2011) 0.99
Hirudin--the long and stony way from an anticoagulant peptide in the saliva of medicinal leech to a recombinant drug and beyond. A historical piece. Thromb Haemost (2007) 0.97
Regulation of hyaluronan synthesis by vasodilatory prostaglandins. Implications for atherosclerosis. Thromb Haemost (2007) 0.97
Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells. Thromb Haemost (2003) 0.96
Kidney transplantation from related and unrelated living donors in a single German centre. Nephrol Dial Transplant (2003) 0.96
Response variability to P2Y12 receptor inhibitors: expectations and reality. JACC Cardiovasc Interv (2013) 0.94
Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. Am J Kidney Dis (2006) 0.93
Iliac artery stenosis proximal to a kidney transplant: clinical findings, duplex-sonographic criteria, treatment, and outcome. Transplantation (2003) 0.93
Peritoneal fluid and solute transport: influence of treatment time, peritoneal dialysis modality, and peritonitis incidence. J Am Soc Nephrol (2002) 0.92
Pharmacophore definition and three-dimensional quantitative structure-activity relationship study on structurally diverse prostacyclin receptor agonists. Mol Pharmacol (2002) 0.92
Thienopyridines in cardiovascular disease: focus on clopidogrel resistance. Thromb Haemost (2007) 0.91
Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. Am J Kidney Dis (2004) 0.90
Risk factors for delayed graft function after renal transplantation and their significance for long-term clinical outcome. Transpl Int (2002) 0.90
Mechanisms of the inhibitory effects of epigallocatechin-3 gallate on platelet-derived growth factor-BB-induced cell signaling and mitogenesis. FASEB J (2003) 0.89
Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins. Circ Res (2004) 0.88
Effect of filtration volume of continuous venovenous hemofiltration in the treatment of patients with acute renal failure in intensive care units. Crit Care Med (2003) 0.88
Complex effects of different green tea catechins on human platelets. FEBS Lett (2003) 0.87
Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart. Cardiovasc Res (2008) 0.87
Dialysis with icodextrin interferes with measurement of serum alpha-amylase activity. Nephrol Dial Transplant (2002) 0.87
ICAM-1 and p38 MAPK mediate fibrinogen-induced migration of human vascular smooth muscle cells. Eur J Pharmacol (2007) 0.87
Proatherogenic effects of estradiol in a model of accelerated atherosclerosis in ovariectomized ApoE-deficient mice. Basic Res Cardiol (2010) 0.86
Cardiospecific overexpression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury. Circulation (2005) 0.85
Opportunistic infections after renal transplantation. Curr Opin Urol (2002) 0.85
Tumor necrosis factor-alpha gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis. Am J Nephrol (2006) 0.84
Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs. Respir Res (2007) 0.84
Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients. Nephrol Dial Transplant (2009) 0.84
Gene expression profile of the Gs-coupled prostacyclin receptor in human vascular smooth muscle cells. Biochem Pharmacol (2004) 0.84
CD40 ligand (CD40L) does not stimulate proliferation of vascular smooth muscle cells. Eur J Cell Biol (2002) 0.84
Alternative splicing of platelet cyclooxygenase-2 mRNA in patients after coronary artery bypass grafting. Thromb Haemost (2007) 0.84
Membrane environment rather than tissue factor expression determines thrombin formation triggered by monocytic cells undergoing apoptosis. J Leukoc Biol (2008) 0.83
Association of interleukin-10 gene G-1082A polymorphism with the progression of primary glomerulonephritis. Kidney Int (2004) 0.83
Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. Nephrol Dial Transplant (2004) 0.83
Ammonia triggers exocytotic release of L-glutamate from cultured rat astrocytes. Glia (2010) 0.82
Clopidogrel inhibits platelet adhesion and platelet-dependent mitogenesis in vascular smooth muscle cells. Thromb Res (2002) 0.82
Cyclooxygenase COX-2a, a novel COX-2 mRNA variant, in platelets from patients after coronary artery bypass grafting. Thromb Haemost (2004) 0.81
High glucose enhances thrombin responses via protease-activated receptor-4 in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2010) 0.81
Fibrillary glomerulonephritis associated with crescents as a therapeutic challenge. Am J Kidney Dis (2002) 0.81
Inhibition of the vascular-endothelial growth factor-induced intracellular signaling and mitogenesis of human endothelial cells by epigallocatechin-3 gallate. Eur J Pharmacol (2004) 0.81
Rapid release of active tissue factor from human arterial smooth muscle cells under flow conditions. Arterioscler Thromb Vasc Biol (2006) 0.81
Histochemical distribution and expression of aquaporin 1 in the peritoneum of patients undergoing peritoneal dialysis: relation to peritoneal transport. Am J Kidney Dis (2004) 0.81
Regulation of functionally active P2Y12 ADP receptors by thrombin in human smooth muscle cells and the presence of P2Y12 in carotid artery lesions. Arterioscler Thromb Vasc Biol (2010) 0.81
Redox regulation of human protease-activated receptor-2 by activated factor X. Free Radic Biol Med (2011) 0.81
Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study. Nephrol Dial Transplant (2007) 0.81
Inhibition of platelet thromboxane receptor function by a thrombin receptor-targeted pepducin. Nat Med (2003) 0.81
Value of diabetes as an independent predictor of death in subjects with end-stage renal disease. Med Klin (Munich) (2006) 0.81
Flow cytometry analysis of platelet cyclooxygenase-2 expression: induction of platelet cyclooxygenase-2 in patients undergoing coronary artery bypass grafting. Br J Haematol (2002) 0.81
Tandem plasmapheresis and haemodialysis as a safe procedure in 82 patients with immune-mediated disease. Nephrol Dial Transplant (2008) 0.80
Activation of IP and EP(3) receptors alters cAMP-dependent cell migration. Eur J Pharmacol (2002) 0.80
Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation. Clin Transplant (2007) 0.79
Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells. Cardiovasc Res (2013) 0.79
Regulation of human vascular protease-activated receptor-3 through mRNA stabilization and the transcription factor nuclear factor of activated T cells (NFAT). Mol Pharmacol (2011) 0.79
How to improve the concept of individualised antiplatelet therapy with P2Y12 receptor inhibitors--is an algorithm the answer? Thromb Haemost (2014) 0.79
The C-terminal peptide of thrombospondin-1 stimulates distinct signaling pathways but induces an activation-independent agglutination of platelets and other cells. FEBS Lett (2003) 0.79
Regulation of cyclooxygenase-2 expression by iloprost in human vascular smooth muscle cells. Role of transcription factors CREB and ICER. Biochem Pharmacol (2003) 0.79
Indicators of acute and persistent renal damage in adult thrombotic microangiopathy. PLoS One (2012) 0.79
Critical limb ischaemia as a main cause of death in patients with end-stage renal disease: a single-centre study. Nephrol Dial Transplant (2004) 0.79
Prostacyclin enhances the expression of LPS/INF-gamma-induced nitric oxide synthase in human monocytes. Nephron (2002) 0.79
Effluent CA 125 concentration in chronic peritoneal dialysis patients: influence of PD duration, peritoneal transport and PD regimen. Kidney Blood Press Res (2003) 0.78
The TT genotype of the C677T polymorphism in the methylentetrahydrofolate reductase as a risk factor in thrombotic microangiopathies: results from a pilot study. Clin Appl Thromb Hemost (2009) 0.78
Differential effects of medroxyprogesterone acetate on thrombosis and atherosclerosis in mice. Br J Pharmacol (2009) 0.78
Early conversion from cyclosporine to tacrolimus increases renal graft function in chronic allograft nephropathy at BANFF stages I and II. Transpl Int (2008) 0.78
Genetic variability in response to clopidogrel therapy and its clinical implications. Thromb Haemost (2011) 0.78
Prevalence and risk factors of pre-diabetes after renal transplantation: a single-centre cohort study in 200 consecutive patients. Nephrol Dial Transplant (2012) 0.78
Targeting phosphoprotein profiling by combination of hydroxyapatite-based phosphoprotein enrichment and SELDI-TOF MS. Arch Physiol Biochem (2010) 0.78
Mycophenolic acid inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of Egr-1 in rat mesangial cells. Nephrol Dial Transplant (2008) 0.78
Long-term-desensitization of prostacyclin receptors is independent of the C-terminal tail. Biochem Pharmacol (2003) 0.78
Variable platelet response to aspirin in patients with ischemic stroke. Cerebrovasc Dis (2007) 0.78
Influence of beta3 integrin gene Leu/Pro33 polymorphism on primary glomerulonephritis. Nephron Exp Nephrol (2004) 0.78
Influence of cytokine gene polymorphisms on IgA nephropathy. Ren Fail (2008) 0.78
Antiinflammatory effects of aspirin in ACS: relevant to its cardiocoronary actions? Thromb Haemost (2015) 0.78